Organization Profile

You just read:

OncoGenex Announces Completion of Patient Enrollment in the Rainier™ Clinical Trial Evaluating Apatorsen in Combination with ABRAXANE® plus Gemcitabine in Patients with Metastatic Pancreatic Cancer

News provided by

OncoGenex Pharmaceuticals, Inc.

Dec 16, 2014, 06:30 ET